PhageLab

行业

数字化与机器人, 渔业与水产养殖, 采后处理与加工, 种子与遗传育种, 兽医

主题

畜禽生产与遗传育种

角色

生产商 — “…ize lytic activity. - Phage manufacturing: cost-efficient, scalable production facility and processes to deliv…”

为何属于生物经济

PhageLab是一家生物技术公司，为畜牧和家禽行业开发基于噬菌体的抗菌解决方案。

发现途径

[Rubric] Bolivia · phages; [Rubric] Brazil · phages; [Rubric] Chile · animal-vaccines; [Rubric] Chile · phages

产品: PHAGEIN; INSPEKTOR; FÓRMIDA

应用

Phage therapy in animal farming · Reducing the load and prevalence of Salmonella in poultry production · Animal health · Food safety · Livestock · Poultry · Agriculture · Aquaculture

产品（官网）

PHAGEIN — Technology developed by PhageLab to combat neonatal calf diarrhea. · PHAGEIN — Technology developed to combat neonatal calf diarrhea. · INSPEKTOR — Product confirmed effective in advancing poultry health. · FÓRMIDA · INSPEKTOR · FÓRMIDA — Lab validation product related to precision in action.

摘自公司官网: about · products · production · rnd · leadership · sustainability · topic · topic

• 2026-04 最新状态: 2026年4月，PhageLab 完成领导层交接：Caue Zortea 出任 CEO，联合创始人 Hans Pieringer 转任首席科学官（CSO）。 ↗ ↗ ↗
• 2026-04-10 PhageLab recaudó USD 3M en una ronda liderada por Kaszek para expandirse en Brasil - Entorno VC
  PhageLab is a biotech startup using bacteriophages, powered by AI and data analytics, to develop targeted alternatives to antibiotics for animals. It just raised a US$3 million bridge round led by Kaszek to accelerate its commercial expansion in Brazil and …
• 2026-04-10 PhageLab Targets Global Expansion After US$3M Round led by Kaszek Ventures
  PhageLab has raised US$3 million (led by Kaszek Ventures) to accelerate its global expansion and commercial growth in animal health, with a leadership shift: co-founder Hans Pieringer becomes CSO and Caue Zortea steps in as CEO to drive go-to-market efforts. …
• 2025-03-12 Esta empresa hace ciencia desde Chile con bacteriófagos para erradicar enfermedades en animales de Latinoamérica: ¿siguen los humanos?
  PhageLab is a Chilean biotech startup using bacteriophages to control harmful bacteria in animals and potentially humans, with recent success selling in Chile, Brazil, and Argentina and about $40 million raised. They are exploring human health applications, …
• 2026-02-17 Strain-level prediction: a new standard in bacteriophage applications - PhageLab
  PhageLab has achieved a milestone by validating strain-level prediction of bacteria–phage interactions using machine learning, showing predictive accuracies of 78–94% and applicability in real production conditions. The work, published in Scientific Reports, …
• 2025-12-19 PhageLab Raises US$3.5M led by Kaszek Ventures to Expand Biotech Solutions for the Supply Chain
  PhageLab has secured over US$3.5 million in a convertible note financing led by Kaszek Ventures, signaling strong investor confidence and a capability to scale its biotech solutions for supply chains. The deal reinforces PhageLab’s position as a leading …
• 2025-08-11 PhageLab recognized as the Best Startup of Start-Up Chile’s 15th Anniversary - PhageLab
  PhageLab was honored as the Best Startup at Start-Up Chile’s 15th Anniversary Demo Day, highlighting the impact of its bacteriophage-based technology and strong team execution within a prestigious Chilean innovation program.

股权与投资方 4

同类企业

Farmabase Saúde Animal Ltda. · CARVAL · VETANCO S.A. · SAN Vet LATAM · LBV Centroamérica · LAVETEC · Laboratorios Microsules Uruguay S.A. · Vaxxinova Brasil